Hans Georg Prof. Sahl
#129,955
Most Influential Person Now
Hans Georg Prof. Sahl's AcademicInfluence.com Rankings
Hans Georg Prof. Sahlbiology Degrees
Biology
#8497
World Rank
#11586
Historical Rank
Microbiology
#433
World Rank
#488
Historical Rank
Download Badge
Biology
Why Is Hans Georg Prof. Sahl Influential?
(Suggest an Edit or Addition)Hans Georg Prof. Sahl's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies (2006) (3456)
- Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. (2013) (1360)
- The co-evolution of host cationic antimicrobial peptides and microbial resistance (2006) (970)
- Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. (1999) (756)
- Specific Binding of Nisin to the Peptidoglycan Precursor Lipid II Combines Pore Formation and Inhibition of Cell Wall Biosynthesis for Potent Antibiotic Activity* (2001) (684)
- Chitosan and its antimicrobial potential – a critical literature survey (2009) (645)
- Insights into the Mode of Action of Chitosan as an Antibacterial Compound (2008) (600)
- Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. (1998) (495)
- Lantibiotics: mode of action, biosynthesis and bioengineering. (2009) (468)
- Plectasin, a Fungal Defensin, Targets the Bacterial Cell Wall Precursor Lipid II (2010) (455)
- Dysregulation of bacterial proteolytic machinery by a new class of antibiotics (2005) (441)
- Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Fast and Reliable Identification of Clinical Yeast Isolates (2009) (437)
- Role of lipid‐bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics (1998) (402)
- Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles (1985) (386)
- Biosynthesis and biological activities of lantibiotics with unique post-translational modifications. (1995) (356)
- The Lantibiotic Mersacidin Inhibits Peptidoglycan Synthesis by Targeting Lipid II (1998) (349)
- Mode of action of modified and unmodified bacteriocins from Gram-positive bacteria. (2002) (333)
- Failures in Clinical Treatment of Staphylococcus aureus Infection with Daptomycin Are Associated with Alterations in Surface Charge, Membrane Phospholipid Asymmetry, and Drug Binding (2007) (306)
- Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall (2013) (282)
- Daptomycin inhibits cell envelope synthesis by interfering with fluid membrane microdomains (2016) (274)
- Metagenome Mining Reveals Polytheonamides as Posttranslationally Modified Ribosomal Peptides (2012) (261)
- Small cationic antimicrobial peptides delocalize peripheral membrane proteins (2014) (248)
- Mechanistic studies of lantibiotic-induced permeabilization of phospholipid vesicles. (1995) (224)
- An oldie but a goodie - cell wall biosynthesis as antibiotic target pathway. (2010) (222)
- Mammalian defensins: structures and mechanism of antibiotic activity (2005) (221)
- Human β-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci (2010) (220)
- Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. (2004) (215)
- The mode of action of the lantibiotic lacticin 3147 – a complex mechanism involving specific interaction of two peptides and the cell wall precursor lipid II (2006) (211)
- Posttranslationally modified bacteriocins--the lantibiotics. (2000) (208)
- The Consequence of Sequence Alteration of an Amphipathic α-Helical Antimicrobial Peptide and Its Diastereomers* (2002) (202)
- The lantibiotic mersacidin inhibits peptidoglycan biosynthesis at the level of transglycosylation. (1997) (196)
- Autolytic system of Staphylococcus simulans 22: influence of cationic peptides on activity of N-acetylmuramoyl-L-alanine amidase (1987) (195)
- Structural analysis and proteolytic activation of Enterococcus faecalis cytolysin, a novel lantibiotic (1996) (190)
- The Wadi Natrun: Chemical composition and microbial mass developments in alkaline brines of Eutrophic Desert Lakes (1979) (189)
- Antibiotic activities of host defense peptides: more to it than lipid bilayer perturbation. (2011) (189)
- New developments in RiPP discovery, enzymology and engineering. (2020) (175)
- Lipid II-Mediated Pore Formation by the Peptide Antibiotic Nisin: a Black Lipid Membrane Study (2004) (171)
- In vitro assembly of a complete, pentaglycine interpeptide bridge containing cell wall precursor (lipid II‐Gly5) of Staphylococcus aureus (2004) (170)
- Antibiotic acyldepsipeptides activate ClpP peptidase to degrade the cell division protein FtsZ (2011) (166)
- Insights into In Vivo Activities of Lantibiotics from Gallidermin and Epidermin Mode-of-Action Studies (2006) (150)
- Multiple activities in lantibiotics--models for the design of novel antibiotics? (2002) (147)
- Induction of autolysis of staphylococci by the basic peptide antibiotics Pep 5 and nisin and their influence on the activity of autolytic enzymes (1985) (143)
- New insights into the mechanism of action of lantibiotics--diverse biological effects by binding to the same molecular target. (2000) (138)
- Mode of action of the lantibiotic mersacidin: inhibition of peptidoglycan biosynthesis via a novel mechanism? (1995) (135)
- Susceptibility of bacterial, eukaryotic and artificial membranes to the disruptive action of the cationic peptides Pep 5 and nisin (1986) (133)
- Production, purification and chemical properties of an antistaphylococcal agent produced by Staphylococcus epidermidis. (1981) (131)
- Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. (2002) (131)
- Extensive Post-translational Modification, Including Serine to d-Alanine Conversion, in the Two-component Lantibiotic, Lacticin 3147* (1999) (130)
- Isolation, Characterization, and Heterologous Expression of the Novel Lantibiotic Epicidin 280 and Analysis of Its Biosynthetic Gene Cluster (1998) (124)
- Two-Component Anti-Staphylococcus aureusLantibiotic Activity Produced by Staphylococcus aureusC55 (1998) (123)
- NMR Study of Mersacidin and Lipid II Interaction in Dodecylphosphocholine Micelles (2003) (123)
- Insight into Invertebrate Defensin Mechanism of Action (2010) (123)
- The Lipopeptide Antibiotic Friulimicin B Inhibits Cell Wall Biosynthesis through Complex Formation with Bactoprenol Phosphate (2009) (122)
- Analysis of the Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrum of Staphylococcus aureus Identifies Mutations That Allow Differentiation of the Main Clonal Lineages (2013) (122)
- Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation. (1995) (121)
- Production of the Novel Two-Peptide Lantibiotic Lichenicidin by Bacillus licheniformis DSM 13 (2009) (120)
- Mode of action of the staphylococcinlike peptide Pep 5: voltage-dependent depolarization of bacterial and artificial membranes (1988) (118)
- Presence of Staphylococcus aureus with Reduced Susceptibility to Vancomycin in Germany (1999) (115)
- Copsin, a Novel Peptide-based Fungal Antibiotic Interfering with the Peptidoglycan Synthesis* (2014) (111)
- Biochemical characterisation and genetic analysis of aureocin A53, a new, atypical bacteriocin from Staphylococcus aureus. (2002) (109)
- Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5 (1996) (108)
- Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance (2009) (105)
- Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase (2017) (104)
- Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus. (2001) (102)
- Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. (2005) (101)
- Naturally Processed Dermcidin-Derived Peptides Do Not Permeabilize Bacterial Membranes and Kill Microorganisms Irrespective of Their Charge (2006) (100)
- Purification and characterization of EpiD, a flavoprotein involved in the biosynthesis of the lantibiotic epidermin (1992) (100)
- The peptide antibiotic subtilin acts by formation of voltage-dependent multi-state pores in bacterial and artificial membranes. (1989) (97)
- Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin (2004) (96)
- Identification and in vitro Analysis of the GatD/MurT Enzyme-Complex Catalyzing Lipid II Amidation in Staphylococcus aureus (2012) (96)
- Protein engineering of lantibiotics (1996) (95)
- Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. (1990) (93)
- Interaction of the pore forming‐peptide antibiotics Pep 5, nisin and subtilin with non‐energized liposomes (1989) (91)
- Specific Interaction of the Unmodified Bacteriocin Lactococcin 972 with the Cell Wall Precursor Lipid II (2008) (89)
- Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential (1996) (88)
- Ca2+-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids (2020) (87)
- Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. (2003) (86)
- Cloning, sequencing and production of the lantibiotic mersacidin. (1995) (85)
- In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. (2004) (82)
- Antimicrobial phenalenone derivatives from the marine-derived fungus Coniothyrium cereale. (2011) (82)
- Proton-Binding Capacity of Staphylococcus aureus Wall Teichoic Acid and Its Role in Controlling Autolysin Activity (2012) (80)
- Functional conservation of the lipid II biosynthesis pathway in the cell wall‐less bacteria Chlamydia and Wolbachia: why is lipid II needed? (2009) (79)
- Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides. (2008) (78)
- Differential expression of α‐ and β‐defensins in human peripheral blood (2003) (76)
- Structural variations of the cell wall precursor lipid II in Gram-positive bacteria - Impact on binding and efficacy of antimicrobial peptides. (2015) (75)
- Proteomic Response of Bacillus subtilis to Lantibiotics Reflects Differences in Interaction with the Cytoplasmic Membrane (2012) (75)
- Tuning the biological properties of amphipathic α-helical antimicrobial peptides: Rational use of minimal amino acid substitutions (2005) (74)
- Influence of the staphylococcinlike peptide Pep 5 on membrane potential of bacterial cells and cytoplasmic membrane vesicles (1985) (74)
- Nucleotide sequence of the lantibiotic Pep5 biosynthetic gene cluster and functional analysis of PepP and PepC. Evidence for a role of PepC in thioether formation (1995) (73)
- Analysis of in vitro activities and modes of action of synthetic antimicrobial peptides derived from an alpha-helical 'sequence template'. (2008) (73)
- Characterization of co-translationally formed nanodisc complexes with small multidrug transporters, proteorhodopsin and with the E. coli MraY translocase. (2012) (72)
- Role of the Single Regulator MrsR1 and the Two-Component System MrsR2/K2 in the Regulation of Mersacidin Production and Immunity (2002) (72)
- Pep5: Structure Elucidation of a Large Lantibiotic (1989) (71)
- Mode of action of human beta-defensin 3 against Staphylococcus aureus and transcriptional analysis of responses to defensin challenge. (2008) (70)
- Producer immunity towards the lantibiotic Pep5: identification of the immunity gene pepI and localization and functional analysis of its gene product (1994) (69)
- Lipid II-Based Antimicrobial Activity of the Lantibiotic Plantaricin C (2006) (67)
- The Lantibiotic NAI-107 Binds to Bactoprenol-bound Cell Wall Precursors and Impairs Membrane Functions* (2014) (67)
- Efflux of low-Mr substances from the cytoplasm of sensitive cells caused by the staphylococcin-like agent Pep 5 (1983) (66)
- The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7 (1996) (65)
- Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7 (1995) (65)
- Identification of Genes Encoding Two-Component Lantibiotic Production in Staphylococcus aureus C55 and Other Phage Group II S. aureus Strains and Demonstration of an Association with the Exfoliative Toxin B Gene (1999) (64)
- Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. (2012) (64)
- The lantibiotic mersacidin is a strong inducer of the cell wall stress response of Staphylococcus aureus (2008) (64)
- Structural similarities of the staphylococcin-like peptide Pep-5 to the peptide antibiotic nisin (1985) (63)
- Expression of the Lantibiotic Mersacidin in Bacillus amyloliquefaciens FZB42 (2011) (61)
- Pep5, a new lantibiotic: structural gene isolation and prepeptide sequence (2004) (61)
- Identification of agr-positive methicillin-resistant Staphylococcus aureus harbouring the class A mec complex by MALDI-TOF mass spectrometry. (2014) (61)
- Identification and optimization of an antimicrobial peptide from the ant venom toxin pilosulin. (2005) (60)
- Purification and Partial Characterization of a Murein Hydrolase, Millericin B, Produced by Streptococcus milleri NMSCC 061 (2000) (60)
- Sequence analysis by NMR spectroscopy of the peptide lantibiotic epilancin K7 from Staphylococcus epidermidis K7. (1995) (60)
- The cell wall precursor lipid II acts as a molecular signal for the Ser/Thr kinase PknB of Staphylococcus aureus. (2017) (60)
- Lahorenoic acids A-C, ortho-dialkyl-substituted aromatic acids from the biocontrol strain Pseudomonas aurantiaca PB-St2. (2013) (60)
- Phosphorylation of Amyloid-β Peptide at Serine 8 Attenuates Its Clearance via Insulin-degrading and Angiotensin-converting Enzymes* (2012) (59)
- Mode of Action of the Antimicrobial Peptide Aureocin A53 from Staphylococcus aureus (2002) (58)
- Preparative Scale Cell-free Production and Quality Optimization of MraY Homologues in Different Expression Modes* (2011) (58)
- Immunity to lantibiotics (1996) (58)
- Lantibiotics and Related Peptides (1998) (58)
- Mechanism of Action and Limited Cross-Resistance of New Lipopeptide MX-2401 (2011) (57)
- Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors. (2012) (57)
- Modulating the activity of short arginine-tryptophan containing antibacterial peptides with N-terminal metallocenoyl groups (2012) (57)
- Transposon Disruption of the Complex I NADH Oxidoreductase Gene (snoD) in Staphylococcus aureus Is Associated with Reduced Susceptibility to the Microbicidal Activity of Thrombin-Induced Platelet Microbicidal Protein 1 (2006) (56)
- Localization and Functional Analysis of PepI, the Immunity Peptide of Pep5-Producing Staphylococcus epidermidis Strain 5 (2004) (56)
- Defensin-based anti-infective strategies. (2014) (55)
- Unique peptide modifications involved in the biosynthesis of lantibiotics. (1995) (55)
- The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques. (2007) (55)
- Lipid II and other bactoprenol-bound cell wall precursors as drug targets. (2010) (54)
- The lantibiotic nisin induces lipid II aggregation, causing membrane instability and vesicle budding. (2015) (54)
- Elucidation of the structure of SA-FF22, a lanthionine-containing antibacterial peptide produced by Streptococcus pyogenes strain FF22. (1994) (53)
- Bactericidal Activity of the Human Skin Fatty Acid cis-6-Hexadecanoic Acid on Staphylococcus aureus (2014) (52)
- Construction of an expression system for engineering of the lantibiotic Pep5 (1994) (52)
- Coordination of capsule assembly and cell wall biosynthesis in Staphylococcus aureus (2019) (52)
- The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. (1994) (52)
- Antimicrobial Host Defensins – Specific Antibiotic Activities and Innate Defense Modulation (2012) (52)
- Cytoplasmic Sulfurtransferases in the Purple Sulfur Bacterium Allochromatium vinosum: Evidence for Sulfur Transfer from DsrEFH to DsrC (2012) (51)
- Eurocin, a New Fungal Defensin (2012) (51)
- Lipid Requirements for the Enzymatic Activity of MraY Translocases and in Vitro Reconstitution of the Lipid II Synthesis Pathway* (2015) (50)
- Molecular Analysis of Expression of the Lantibiotic Pep5 Immunity Phenotype (1999) (49)
- Very Low Ethanol Concentrations Affect the Viability and Growth Recovery in Post-Stationary-Phase Staphylococcus aureus Populations (2006) (46)
- Elucidation of the primary structure of the lantibiotic epilancin K7 from Staphylococcus epidermidis K7. Cloning and characterisation of the epilancin-K7-encoding gene and NMR analysis of mature epilancin K7. (1995) (45)
- Thiosulfate Transfer Mediated by DsrE/TusA Homologs from Acidothermophilic Sulfur-oxidizing Archaeon Metallosphaera cuprina* (2014) (45)
- Staphylococcin 1580 is identical to the lantibiotic epidermin: implications for the nature of bacteriocins from gram-positive bacteria (1994) (45)
- Model membrane studies for characterization of different antibiotic activities of lipopeptides from Pseudomonas. (2012) (45)
- Identification and analysis of a gene encoding a Fur-like protein of Staphylococcus epidermidis. (1996) (44)
- Differentiation of Staphylococcus argenteus (formerly: Staphylococcus aureus clonal complex 75) by mass spectrometry from S. aureus using the first strain isolated from a wild African great ape. (2017) (41)
- Functional Analysis of the Cytoskeleton Protein MreB from Chlamydophila pneumoniae (2011) (41)
- Biosynthetic Origin of the Antibiotic Cyclocarbamate Brabantamide A (SB‐253514) in Plant‐Associated Pseudomonas. (2014) (41)
- Pseudomycoicidin, a Class II Lantibiotic from Bacillus pseudomycoides (2015) (41)
- Ultrashort Peptide Bioconjugates Are Exclusively Antifungal Agents and Synergize with Cyclodextrin and Amphotericin B (2011) (41)
- Insights into the Mode of Action of Chitosan as an Antibacterial Compound (2008) (40)
- Effect of leader peptide mutations on biosynthesis of the lantibiotic Pep5. (1997) (40)
- Structural Variations of the Cell Wall Precursor Lipid II and Their Influence on Binding and Activity of the Lipoglycopeptide Antibiotic Oritavancin (2014) (37)
- GIS-supported investigation of a nosocomial Salmonella outbreak. (2000) (35)
- The genetics of lantibiotic biosynthesis (1995) (35)
- Mode of action of the staphylococcin-like peptide Pep 5 and culture conditions effecting its activity. (1982) (35)
- Requirement of lipid II biosynthesis for cell division in cell wall-less Wolbachia, endobacteria of arthropods and filarial nematodes. (2013) (35)
- Combination of antibiotic mechanisms in lantibiotics. (2002) (35)
- Gene-encoded antibiotics made in bacteria. (1994) (34)
- Bridged Epipolythiodiketopiperazines from Penicillium raciborskii, an Endophytic Fungus of Rhododendron tomentosum Harmaja. (2016) (34)
- New Proteins Involved in Sulfur Trafficking in the Cytoplasm of Allochromatium vinosum* (2014) (34)
- Killing of Staphylococci by θ-Defensins Involves Membrane Impairment and Activation of Autolytic Enzymes (2014) (33)
- Differential daptomycin resistance development in Staphylococcus aureus strains with active and mutated gra regulatory systems. (2017) (33)
- Influence of cationic peptides on the activity of the autolytic endo-beta-N-acetylglucosaminidase of Staphylococcus simulans 22. (1989) (32)
- Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria. (1993) (32)
- AmiA is a penicillin target enzyme with dual activity in the intracellular pathogen Chlamydia pneumoniae (2014) (31)
- Plasmid involvement in production of and immunity to the staphylococcin-like peptide Pep 5. (1984) (31)
- Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors. (2015) (30)
- On the antibiotic and antifungal activity of pestalone, pestalachloride A, and structurally related compounds. (2013) (29)
- The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of β-Lactams against MRSA by Inhibiting Pentaglycine Interpeptide Bridge Synthesis (2012) (29)
- Discovery of the Cyclic Lipopeptide Gacamide A by Genome Mining and Repair of the Defective GacA Regulator in Pseudomonas fluorescens Pf0-1. (2019) (29)
- The pentaglycine bridges of Staphylococcus aureus peptidoglycan are essential for cell integrity (2018) (29)
- Influence of Ca2+ Ions on the Activity of Lantibiotics Containing a Mersacidin-Like Lipid II Binding Motif (2009) (28)
- Carnocin UI49, a potential biopreservative produced by Carnobacterium piscicola: large scale purification and activity against various gram-positive bacteria including Listeria sp. (1993) (28)
- Development of in vitro resistance to chitosan is related to changes in cell envelope structure of Staphylococcus aureus. (2017) (28)
- Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. (1992) (28)
- New strategies and compounds for anti-infective treatment. (2013) (27)
- Antimicrobial Peptides from the Aurein Family Form Ion‐Selective Pores in Bacillus subtilis (2015) (27)
- Docking on Lipid II-A Widespread Mechanism for Potent Bactericidal Activities of Antibiotic Peptides. (2019) (27)
- Identification of defensin-encoding genes of Picea glauca: characterization of PgD5, a conserved spruce defensin with strong antifungal activity (2012) (27)
- Bacterial resistance to antimicrobial peptides. (2015) (26)
- Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae (2014) (25)
- Anti-infective strategies of the future: is there room for species-specific antibacterial agents? (2010) (25)
- Artificial beta-defensin based on a minimal defensin template. (2009) (24)
- Biosynthetic Origin of the Antibiotic Pseudopyronines A and B in Pseudomonas putida BW11M1 (2015) (23)
- Antibiotic-Induced Autoactivation of IS256 in Staphylococcus aureus (2013) (23)
- Bactericidal cationic peptides involved in bacterial antagonism and host defence. (1985) (22)
- Staphylococcus aureus Small Colony Variants Cause Persistent and Resistant Infections (1996) (22)
- Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity. (2013) (21)
- Lipodepsipeptide Empedopeptin Inhibits Cell Wall Biosynthesis through Ca2+-dependent Complex Formation with Peptidoglycan Precursors* (2012) (21)
- Interaction of the staphylococcin-like peptide Pep 5 with cell walls and isolated cell wall components of Gram-positive bacteria. (1985) (20)
- Trivalent ultrashort lipopeptides are potent pH dependent antifungal agents. (2012) (20)
- Membrane Lipids Determine the Antibiotic Activity of the Lantibiotic Gallidermin (2008) (19)
- ChBac3.4: A Novel Proline-Rich Antimicrobial Peptide from Goat Leukocytes (2009) (19)
- Multiple Activities in Natural Antimicrobials (2008) (18)
- Family of class I lantibiotics from actinomycetes and improvement of their antibacterial activities. (2015) (17)
- esized and post-translationally modi fi ed peptide natural products : overview and recommendations for a universal nomenclature (2012) (15)
- Structural dynamics of the cell wall precursor lipid II in the presence and absence of the lantibiotic nisin. (2014) (15)
- Erratum: Ribosomally synthesized and post-translationally modified peptide natural products: Overview and recommendations for a universal nomenclature (Natural Product Reports (2013) 30 (108-160) DOI:10.1039/C2NP20085F) (2013) (15)
- ChBac3.4: A Novel Proline-Rich Antimicrobial Peptide from Goat Leukocytes (2009) (15)
- Effects of the lantibiotic mersacidin on the morphology of staphylococci. (1996) (14)
- Investigations to the Antibacterial Mechanism of Action of Kendomycin (2016) (14)
- Research letterSusceptibility of bacterial, eukaryotic and artificial membranes to the disruptive action of the cationic peptides Pep 5 and nisin (1986) (12)
- Enzymes of CO2 fixation in chromatiaceae (1977) (12)
- Purification and properties of LIQ 4, an antibacterial substance produced by Streptococcus faecalis var. liquefaciens K 4 (1985) (11)
- Isolation and mode of action of a staphylococcin-like substance active against gram-positive and gram-negative bacteria. (1984) (10)
- Synergistic activity of a short lipidated antimicrobial peptide (lipoAMP) and colistin or tobramycin against Pseudomonas aeruginosa from cystic fibrosis patients (2016) (10)
- Identification of antibacterial peptides from endophytic microbiome (2016) (9)
- Sulfide Protects Staphylococcus aureus from Aminoglycoside Antibiotics but Cannot Be Regarded as a General Defense Mechanism against Antibiotics (2018) (9)
- Isolation of a new epidermin variant from two strains of Staphylococcus epidermidis--frequency of lantibiotic production in coagulase-negative staphylococci. (1996) (8)
- Optimizing antimicrobial host defense peptides. (2006) (8)
- Chemistry and Structure (1998) (8)
- Lanthionine-Containing Bacterial Peptides (2001) (7)
- Specific interaction of the lantibiotic nisin with lipid II leads to highly efficient pore formation (2001) (7)
- Deficient Lipid A Remodeling by the arnB Gene Promotes Biofilm Formation in Antimicrobial Peptide Susceptible Pseudomonas aeruginosa. (2018) (7)
- A quinolinol-based small molecule with anti-MRSA activity that targets bacterial membrane and promotes fermentative metabolism (2017) (6)
- Co-Solvents as Stabilizing Agents during Heterologous Overexpression in Escherichia coli – Application to Chlamydial Penicillin-Binding Protein 6 (2015) (6)
- Chapter 19 – Lantibiotics (2013) (6)
- Different mechanisms of insensitivity to the staphylococcin-like peptide Pep 5. (1987) (5)
- Antibacterial activities of Candida yeasts. Partial purification and characterization of the active substance of Candida guilliermondii. (1982) (5)
- Combination of Antibiotic Mechanisms in Lantibiotics (2003) (5)
- Purification and properties of LIQ 4, an antibacterial substance produced by Streptococcus faecalis var. liquefaciens K4. (1985) (5)
- CHAPTER 16 – Lantibiotics (2006) (4)
- Opposing Effects of PhoPQ and PmrAB on the Properties of Salmonella enterica serovar Typhimurium: Implications on Resistance to Antimicrobial Peptides (2021) (4)
- Analysis of the MALDI-TOF mass spectrum of Staphylococcus aureus (2013) (3)
- Determination of Bacterial Membrane Impairment by Antimicrobial Agents. (2017) (3)
- Elucidation of the primary structure of the lantibiotic epilancin K from Staphylococcus epidermidis K7: Cloning and characterization of the structural gene and NMR analysis of the mature epilancin K7. (1995) (3)
- The search for new anti-infective drugs: untapped resources and strategies. (2014) (2)
- Synthetic antimicrobial peptides designed from sequence templates (2003) (2)
- Antibiotic Activities of Host Defense Peptides: More to it than Lipid Bilayer Perturbation (2011) (2)
- Identification of 5-(Aryl/Heteroaryl)amino-4-quinolones as Potent Membrane-Disrupting Agents to Combat Antibiotic-Resistant Gram-Positive Bacteria. (2022) (2)
- Plectasin, a fungal defensin antibiotic peptide, targets the bacterial cell wall precursor Lipid II (2009) (2)
- Malic enzyme of Chromatium vinosum (1980) (2)
- Lytic activities, protein profiles and morphologic characteristics of new bacteriophages isolated from canine and human Staphylococcus aureus strains. (1992) (2)
- The Staphylococcus aureus Membrane Protein SA2056 Interacts with Peptidoglycan Synthesis Enzymes (2013) (1)
- Biosynthesis of the Lantibiotic Pep5 and Mode of Action of Type A Lantibiotics (1992) (1)
- Lantibiotic Leader Peptidases (2013) (1)
- Corrigendum: Dysregulation of bacterial proteolytic machinery by a new class of antibiotics (2005) (1)
- Antibacterial nucleoside-analog inhibitor of bacterial RNA polymerase: pseudouridimycin (2017) (1)
- Identification of defensin-encoding genes of Picea glauca: characterization of PgD5, a conserved spruce defensin with strong antifungal activity (2012) (1)
- Control of Local Bacterial Soft Tissue Contamination by Adequate Microvascular Response is Critically Dependent on the Extent of Bacterial Challenge (2001) (1)
- [Infantile Campylobacter enteritis (author's transl)]. (1981) (1)
- Biological Roles and Therapeutical Potential of Cationic Host Defence Peptides (2010) (1)
- Proteomic response of Bacillus subtilis to lantibiotics reflects differences in 1 interaction with the cytoplasmic membrane 2 3 Running title : Proteomic response to lantibiotics (2012) (1)
- recombinant mersacidin and a method for its production. (1994) (1)
- Genome mining of the rhizosphere bacterium Pseudomonas sp. SHC52 (2014) (0)
- EXPRESSION OF alpha- AND beta-DEFENSIN mRNA IN HUMAN PERIPHERAL BLOOD (1999) (0)
- Eurocin solution structure (2012) (0)
- Identification of antibacterial peptides from endophytic microbiome (2016) (0)
- [Extent of bacterial contamination is a derminant fur microvascular damage in soft tissue infection]. (1998) (0)
- NMR solution structure of type-B lantibiotics mersacidin in DPC micelles (2003) (0)
- Bacterial proteolytic machinery unleashed by acyldepsipeptide antibiotics (2007) (0)
- NMR solution structure of type-B lantibiotics mersacidin bound to lipid II in DPC micelles (2003) (0)
- Determination of Bacterial Membrane Impairment by Antimicrobial Agents. (2023) (0)
- NMR Solution Structure of Type-B Lantibiotics Mersacidin in MeOH/H2O Mixture (2003) (0)
- Recombinant mersacidin and to a process for the preparation thereof (1994) (0)
- Molecular Genetics of Biosynthesis (1998) (0)
- Recombinant Mersacidin and process for its preparation (1994) (0)
- Answer to Photo Quiz: Pseudozyma aphidis (2013) (0)
- The pentaglycine bridges of Staphylococcus aureus peptidoglycan are essential for cell integrity (2019) (0)
- Introduction to the Lantibiotics session (1992) (0)
- Contents, Supplement 2, 1996 (1996) (0)
- Antibodies detecting gene products involved in lantibiotic biosynthesis (1993) (0)
- The Future: Biotechnology (1998) (0)
- Producer Self-Protection—Immunity (1998) (0)
- Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes (2022) (0)
- MODES OF ANTIBIOTIC ACTION OF HUMAN DEFENSE PEPTIDES: 28 (2004) (0)
- Antibiotic-induced auto-activation of IS 256 in Staphylococcus aureus 1 2 (2013) (0)
- Coordination of capsule assembly and cell wall biosynthesis in Staphylococcus aureus (2019) (0)
- Fluorescence Microscopy Monitoring of Nisin Binding to Bactoprenol Bound Cell Wall Precursors (2012) (0)
- Mode of action of type-A ( II ) lantibiotic : a lipid II-binding motif for nukacin ISK-1 (2012) (0)
- Pep5: Elucidation of the Structure of a Large Lantibiotic. (1989) (0)
- Precursor Lipid II Plectasin , a Fungal Defensin , Targets the Bacterial Cell Wall (2014) (0)
- Translocator-Associated Bacteriocin Leader Peptidase (2013) (0)
- Genetic Engineering of Lantibiotics (1998) (0)
- Management of the emotional factor in the practice of internal medicine. (1957) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hans Georg Prof. Sahl?
Hans Georg Prof. Sahl is affiliated with the following schools:
